Quick Takeaways
- Vivo Opportunity Fund Holdings, L.P. filed SCHEDULE 13G for Camp4 Therapeutics Corp Common Stock, par value $0.0001 per share (CAMP).
- Disclosed ownership: 7.6%.
- Date of event: 11 Sep 2025.
Vivo Opportunity Fund Holdings, L.P. - 11 Sep 2025 SCHEDULE 13G Report for Camp4 Therapeutics Corp Common Stock, par value $0.0001 per share (CAMP)
- Filing Manager
- Vivo Opportunity Fund Holdings, L.P.
- Reporting Manager
- Vivo Opportunity Fund Holdings, L.P.
- Symbol
- CAMP
- Shares outstanding
- 46,865,697 shares
- Disclosed Ownership
- 3,561,793 shares
- Ownership
- 7.6%
- Form type
- SCHEDULE 13G
- Filing time
- 17 Sep 2025, 18:31:01 UTC
- Date of event
- 11 Sep 2025
- Next filing
- 13 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Vivo Opportunity Fund Holdings, L.P. disclosed 7.6% ownership in Camp4 Therapeutics Corp Common Stock, par value $0.0001 per share (CAMP) on 11 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 17 Sep 2025, 18:31.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Vivo Opportunity Fund Holdings, L.P. | 7.6% | 3,561,793 | 3,561,793 | 0 | /s/ Kevin Dai | Kevin Dai/Managing Member | |
| Vivo Opportunity, LLC | 7.6% | 3,561,793 | 3,561,793 | 0 | /s/ Kevin Dai | Kevin Dai/Managing Member | |
| Vivo Opportunity Cayman Fund, L.P. | 0.8% | 359,775 | 359,775 | 0 | /s/ Kevin Dai | Kevin Dai/Managing Member | |
| Vivo Opportunity Cayman, LLC | 0.8% | 359,775 | 359,775 | 0 | /s/ Kevin Dai | Kevin Dai/Managing Member |